Skip to Main content Skip to Navigation
Journal articles

TP53 status and response to treatment in breast cancers.

Abstract : The p53 wild-type protein plays an important role in cells as is shown by its fine regulation at different levels. Since its discovery, numerous mutations have been described. In breast cancers, p53 is mutated in almost 30% of cases, with a higher frequency in some tumor subtypes. TP53 mutation is reported to be a factor for good prognosis in some studies, while in others it is a factor for poor prognosis. The explanation for these different results could be linked to the fact that the studies were performed on different tumor types and with different therapy regimens.
Document type :
Journal articles
Complete list of metadata

Cited literature [94 references]  Display  Hide  Download
Contributor : Philippe Ratajczak Connect in order to contact the contributor
Submitted on : Thursday, October 11, 2012 - 4:51:31 PM
Last modification on : Saturday, June 25, 2022 - 8:52:40 PM
Long-term archiving on: : Saturday, December 17, 2016 - 12:21:42 AM


Publisher files allowed on an open archive




Mariana Varna, Guilhem Bousquet, Louis-François Plassa, Philippe Bertheau, Anne Janin. TP53 status and response to treatment in breast cancers.. Journal of Biomedicine and Biotechnology, Hindawi Publishing Corporation, 2011, 2011, pp.284584. ⟨10.1155/2011/284584⟩. ⟨inserm-00741097⟩



Record views


Files downloads